Across the development lifecycle, our integrated solutions and cross-functional team provide customized support for your program—from the earliest stages of strategy and planning through FDA approval to commercialization.
Ensure flawless interactions with regulatory agencies—from initial strategy, to submissions and meetings—informed by frequent interactions and up-to-date information.
Avoid unnecessary delays and costs by integrating CMC components early in the development program, including strategic insights and management of vendors, processes and quality controls.
Reduce short- and long-term costs through a robust nonclinical program with support in methodology and strategy, study design, development and accountability for program execution.
Move your product efficiently through the clinic using a customized clinical design solution with an eye towards differentiated product labeling.
Clinical & PK
Camargo Capital invests in early-stage biopharma and biotech companies who share our vision to address unmet patient needs through breakthrough science.